SPDR S&P Biotech ETF Rating $94.01 +0.84 (+0.90%) (As of 11/20/2024 ET) Add Compare Share Share Ratings Stock AnalysisChartDividendHeadlinesHoldingsOwnershipRatings SPDR S&P Biotech ETF Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.XBI Aggregate RatingModerate Buy 2.77Holdings in XBI have an aggregate rating of Moderate Buy based on 769 analyst ratings issued in the past year covering 50 companies (74.9% of the portfolio).XBI Aggregate Price Target$94.01High Prediction$94.01Average Prediction$94.01Low Prediction$94.01Holdings in XBI have an aggregate price target of $94.01 and a range of $94.01 to $94.01 covering 50 companies (74.9% of the portfolio).XBI Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy15 Buy rating(s)Moderate Buy29 Moderate Buy rating(s)Hold6 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by SPDR S&P Biotech ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 50 XBI Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings3.10%INCYIncyte$71.05+0.7%3.9 of 5 stars2.38$77.16 8.6%21Analyst Forecast2.85%UTHRUnited Therapeutics$364.33+1.0%4.5219 of 5 stars2.73$370.86 1.8%15Positive News2.83%GILDGilead Sciences$88.63+1.0%4.549 of 5 stars2.65$94.00 6.1%26Analyst ForecastPositive News2.56%NTRANatera$167.88+3.6%2.8018 of 5 stars3.00$140.59 -16.3%17Analyst Forecast2.55%ALNYAlnylam Pharmaceuticals$248.79+6.2%4.3868 of 5 stars2.71$298.09 19.8%24Analyst Forecast2.51%NBIXNeurocrine Biosciences$123.29+3.5%4.9503 of 5 stars2.83$163.91 32.9%24Positive News2.50%VRTXVertex Pharmaceuticals$451.23+0.7%4.0443 of 5 stars2.53$499.12 10.6%30Analyst DowngradePositive News2.34%AMGNAmgen$287.87+2.8%4.9084 of 5 stars2.46$333.57 15.9%26Ex-DividendShort Interest ↓2.32%INSMInsmed$72.67-1.4%3.967 of 5 stars3.00$83.07 14.3%162.28%VKTXViking Therapeutics$51.53+0.0%4.7705 of 5 stars3.09$109.80 113.1%11Analyst ForecastGap Up2.28%SRPTSarepta Therapeutics$110.86+4.0%4.9373 of 5 stars3.00$181.33 63.6%22Analyst DowngradeGap Up2.17%ABBVAbbVie$167.74+0.7%4.9604 of 5 stars2.90$203.37 21.2%21Analyst ForecastPositive News2.16%MDGLMadrigal Pharmaceuticals$317.09+0.9%3.7989 of 5 stars2.69$347.33 9.5%13Analyst Forecast2.13%BIIBBiogen$156.00+0.4%4.8601 of 5 stars2.54$258.96 66.0%28Analyst Downgrade1.89%BMRNBioMarin Pharmaceutical$62.56+1.0%4.9885 of 5 stars2.74$94.20 50.6%231.89%EXASExact Sciences$52.70-2.3%4.8868 of 5 stars2.95$74.47 41.3%19Positive News1.79%CYTKCytokinetics$49.86-2.4%3.8052 of 5 stars2.75$83.67 67.8%16Analyst ForecastInsider TradeOptions VolumeNews Coverage1.73%REGNRegeneron Pharmaceuticals$743.35-0.2%4.7877 of 5 stars2.78$1,099.55 47.9%231.68%CRSPCRISPR Therapeutics$47.26+0.6%1.771 of 5 stars2.37$74.94 58.6%191.67%BPMCBlueprint Medicines$94.81+0.2%2.713 of 5 stars2.71$122.11 28.8%21Analyst Forecast1.62%HALOHalozyme Therapeutics$45.76+2.1%4.9806 of 5 stars2.60$61.11 33.5%10Analyst Forecast1.51%MRNAModerna$36.94-0.9%4.6286 of 5 stars2.18$84.00 127.4%22Analyst UpgradeAnalyst Revision1.49%TGTXTG Therapeutics$31.15+2.7%4.2148 of 5 stars2.83$37.67 20.9%6Positive News1.45%RVMDRevolution Medicines$57.07+1.1%2.7869 of 5 stars3.08$61.00 6.9%121.34%RNAAvidity Biosciences$43.65+0.9%2.3883 of 5 stars3.00$63.22 44.8%9Insider TradeAnalyst Revision1.28%KRYSKrystal Biotech$178.10+0.1%4.8348 of 5 stars3.00$202.29 13.6%8Positive News1.25%ADMAADMA Biologics$21.37+3.6%3.3139 of 5 stars3.25$21.25 -0.6%41.14%EXELExelixis$34.65+0.7%4.7763 of 5 stars2.65$31.44 -9.3%20Insider Trade1.11%ROIVRoivant Sciences$11.49+1.6%3.2837 of 5 stars2.88$17.93 56.0%81.10%IONSIonis Pharmaceuticals$35.40+4.9%4.2197 of 5 stars2.68$60.65 71.3%191.10%ALKSAlkermes$27.91+1.6%4.7788 of 5 stars2.58$35.42 26.9%12Positive News1.03%BHVNBiohaven$46.81+1.1%3.9152 of 5 stars3.07$63.42 35.5%140.99%IOVAIovance Biotherapeutics$8.14-0.6%4.0475 of 5 stars2.89$22.33 174.4%9Options Volume0.95%PCVXVaxcyte$85.96-1.3%3.2906 of 5 stars3.00$147.50 71.6%70.94%TWSTTwist Bioscience$41.11-0.5%4.1398 of 5 stars2.67$51.78 25.9%9Analyst ForecastAnalyst Revision0.91%BBIOBridgeBio Pharma$23.04+2.2%4.5782 of 5 stars2.87$47.57 106.5%15Insider TradeAnalyst Revision0.86%APLSApellis Pharmaceuticals$27.49-5.2%4.5376 of 5 stars2.79$51.06 85.7%190.85%ACLXArcellx$87.22-0.4%2.9241 of 5 stars3.07$103.08 18.2%14Short Interest ↓0.84%GERNGeron$3.99+5.3%3.492 of 5 stars3.00$7.05 76.7%110.83%CRNXCrinetics Pharmaceuticals$56.07+1.6%3.5524 of 5 stars2.91$70.18 25.2%11Analyst Revision0.81%BEAMBeam Therapeutics$24.49-3.2%2.9185 of 5 stars2.75$44.91 83.4%120.77%AGIOAgios Pharmaceuticals$54.62+0.4%3.3124 of 5 stars2.50$52.33 -4.2%80.76%RXRXRecursion Pharmaceuticals$6.04-3.7%1.9971 of 5 stars2.40$9.25 53.1%5Analyst ForecastOptions VolumeHigh Trading Volume0.75%ACADACADIA Pharmaceuticals$16.27+0.4%3.9106 of 5 stars2.65$25.56 57.1%17Insider TradeAnalyst Revision0.71%RAREUltragenyx Pharmaceutical$46.40+2.8%4.6401 of 5 stars2.92$86.69 86.8%130.68%IMVTImmunovant$26.17+3.8%1.5467 of 5 stars3.00$48.10 83.8%110.66%DYNDyne Therapeutics$29.99+1.0%3.3831 of 5 stars3.00$51.40 71.4%10Insider TradeAnalyst Revision0.66%SWTXSpringWorks Therapeutics$37.44-1.3%2.0472 of 5 stars3.00$67.00 79.0%7Analyst Forecast0.65%PTCTPTC Therapeutics$41.96+6.6%2.5538 of 5 stars2.33$42.00 0.1%15Analyst Downgrade0.64%NTLAIntellia Therapeutics$13.12-7.1%4.5389 of 5 stars2.72$54.94 318.7%18Analyst Forecast This page (NYSEARCA:XBI) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SPDR S&P Biotech ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share SPDR S&P Biotech ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
